Tralokinumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
MedImmune LLC
Overview
Tralokinumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tralokinumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tralokinumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.